Bio-Rad Laboratories, Inc. (BIO) Stock Overview

NYSE · Healthcare · Medical Devices

✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026

$386.11
Price
$10.32B
Market Cap
46.97
P/E Ratio
$8.22
EPS
$396.23
52-Week High
$236.73
52-Week Low
—
Dividend Yield
USD
Currency

About Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.

Source: Yahoo Finance

Sector & Industry

Bio-Rad Laboratories, Inc. operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NYSE exchange.

Bio-Rad Laboratories, Inc. at a Glance

CompanyBio-Rad Laboratories, Inc.
TickerBIO
ExchangeNYSE
CurrencyUSD
Price$386.11
Market cap$10.32B
P/E ratio (trailing)46.97
EPS (trailing)$8.22
52-week high$396.23
52-week low$236.73
Dividend yield—
Ex-dividend date—
Beta1.07
Return on equity (ROE)3.11%
Debt-to-equity19.10%
Average volume298,379
Shares outstanding21.68M
SectorHealthcare
IndustryMedical Devices
Employees7,450
CountryUnited States

Investing Essentials

As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.

AMAZON The Intelligent Investor

Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.

Check Price →
AMAZON One Up On Wall Street

Peter Lynch on how everyday investors can spot winners before the professionals do.

Check Price →
AMAZON Healthcare Investing Reads

Evaluating pharma pipelines, devices and healthcare economics.

Check Price →
Disclaimer: This page is for reference only. Not financial advice. Data is a snapshot and may be out of date. Always verify with a licensed broker.

Frequently Asked Questions

What is Bio-Rad Laboratories, Inc.'s current P/E ratio?
Bio-Rad Laboratories, Inc. (BIO) has a trailing P/E ratio of 46.97 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
What is Bio-Rad Laboratories, Inc.'s market capitalisation?
Bio-Rad Laboratories, Inc.'s market cap is $10.32B based on our latest snapshot. See how it ranks by market cap →
What is BIO's 52-week range?
Over the past 52 weeks, BIO has traded between $236.73 and $396.23. What does the 52-week range mean? →
How volatile is Bio-Rad Laboratories, Inc. compared to the market?
Bio-Rad Laboratories, Inc. has a beta of 1.07, meaning it has historically moved more than the broader market. What does beta measure? →
Does Bio-Rad Laboratories, Inc. pay a dividend?
Bio-Rad Laboratories, Inc. does not currently pay a dividend according to our latest data.
What exchange is BIO listed on?
BIO is listed on the NYSE. Browse all NYSE-listed stocks →
What sector is Bio-Rad Laboratories, Inc. in?
Bio-Rad Laboratories, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →

Working out potential returns or position sizes? Our payout and odds calculators handle the maths.

Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.

Recommended Reading & Tools

AMAZON The Psychology of Money

Morgan Housel's short lessons on behaviour, luck and long-term wealth.

Check Price →
AMAZON A Random Walk Down Wall Street

Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.

Check Price →
AMAZON Common Stocks and Uncommon Profits

Philip Fisher on what makes a business worth owning for the long term.

Check Price →

Related Healthcare Stocks